The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Comorbidities and Mortality in Persons With Schizophrenia: A Swedish National Cohort Study
Abstract
OBJECTIVE: Schizophrenia is associated with premature mortality, but the specific causes and pathways are unclear. The authors used outpatient and inpatient data for a national population to examine the association between schizophrenia and mortality and comorbidities. METHOD: This was a national cohort study of 6,097,834 Swedish adults, including 8,277 with schizophrenia, followed for 7 years (2003-2009) for mortality and comorbidities diagnosed in any outpatient or inpatient setting nationwide. RESULTS: On average, men with schizophrenia died 15 years earlier, and women 12 years earlier, than the rest of the population, and this was not accounted for by unnatural deaths. The leading causes were ischemic heart disease and cancer. Despite having twice as many health care system contacts, schizophrenia patients had no increased risk of nonfatal ischemic heart disease or cancer diagnoses, but they had an elevated mortality from ischemic heart disease (adjusted hazard ratio for women, 3.33 [95% CI=2.73-4.05]; for men, 2.20 [95% CI=1.83-2.65]) and cancer (adjusted hazard ratio for women, 1.71 [95% CI=1.38-2.10; for men, 1.44 [95% CI=1.15-1.80]). Among all people who died from ischemic heart disease or cancer, schizophrenia patients were less likely than others to have been diagnosed previously with these conditions (for ischemic heart disease, 26.3% compared with 43.7%; for cancer, 73.9% compared with 82.3%). The association between schizophrenia and mortality was stronger among women and the employed. Lack of antipsychotic treatment was also associated with elevated mortality. CONCLUSIONS: Schizophrenia patients had markedly premature mortality, and the leading causes were ischemic heart disease and cancer, which appeared to be underdiagnosed. Preventive interventions should prioritize primary health care tailored to this population, including more effective risk modification and screening for cardiovascular disease and cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cardiovascular disease emerges as the leading cause of premature mortality in individuals with SMI, as supported by substantial evidence [19–22].”
From A retrospective and comprehensive analysis of excess life-years lost, mortality risk, and cause of death among severe mental illness in China (2025) · cites this paper as [21]
In the citing paper
“The same method was used in a study from Sweden that found that persons with schizophrenia died 15 years (men) and 12 years (women) earlier than the general population (Crump et al. 2013).”
From Excess early mortality in schizophrenia. (2014) · cites this paper as Crump et al. 2013
In the citing paper
“Evidence as to whether excess mortality is predominantly due to unnatural or natural causes of death remains equivocal.2,7,9,12”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
In the citing paper
“Conflicting results have been recently reported as to whether illicit drug use contributes to excess mortality in psychosis.2,25,26”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
In the citing paper
“People with schizophrenia and other psychotic disorders die earlier than their peers in the general population, with recent estimates suggesting by around 15–20 years.1–10”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
In the citing paper
“overall, findings on the association between exposure to antipsychotic medication and natural-cause mortality remain inconsistent.2,48,49”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
In the citing paper
“Over the past decades, consistent evidence has accrued that people with psychotic disorder have higher mortality rates than the general population.1–9”
From Mortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort (2015) · cites this paper as [2]
Citations
Cites
External review and validation of the Swedish national inpatient register
Ludvigsson, J. F., Andersson, E., Ekbom, A., Feychting, M., Kim, J.-L., Reuterwall, C., Heurgren, M., & Olausson, P. O. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-450 · Cited by 5,055
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Saha, S., Chant, D., & McGrath, J. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.10.1123 · Cited by 2,065
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60742-x · Cited by 1,354
de Leon, J., & Diaz, F. J. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.010 · Cited by 1,276
Atypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194
Schizophrenia and increased risks of cardiovascular disease
Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070
The unhealthy lifestyle of people with schizophrenia
Brown, S., Birtwistle, J., ROE, L., & THOMPSON, C. (1999) · Psychological Medicine · doi:10.1017/s0033291798008186 · Cited by 880
Twenty-five year mortality of a community cohort with schizophrenia
Brown, S., Kim, M., Mitchell, C., & Inskip, H. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067512 · Cited by 601
Research works printed but not linked: 6
- National Board of Health and Welfare, 2011, Causes of Death 2010
- Garrett JM, 1997, Stata Technical Bulletin, 35, 9
- StataCorp, 2010, Stata Statistical Software: Release 11.0
- Ji J, Schizophr Bull
- van de Mheen PJ, 1996, Public Health Rep, 111, 420
- Lahti M, Psychol Med
Cited by
Sorted by citations
Items 501–600 of 618
Medical Issues in Older Adults with Schizophrenia
Copeli, F., & Cohen, C. I. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108539593.008 · Cited by 1
Screening for obstructive lung disease in hospitalized psychiatric patients
Midtgarden, J. M., Renstrøm, N., Obling, N., & Bødtger, U. C. S. (2020) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2019.1687749 · Cited by 1
Moga, C. I., Micluția, I., & Crișan, C. A. (2023) · Medicina Moderna - Modern Medicine · doi:10.31689/rmm.2023.30.2.101 · Cited by 1
Mental disorders and physical activity: Epidemiological analyses using Australian datasets
Suetani, S. (2019) · The University of Queensland · doi:10.14264/uql.2019.592 · Cited by 1
Blomqvist, M. (2020) · Hogskolan Ihalmstad (Halmstad University) · Cited by 1
Pivotal role of Disrupted-in-Schizophrenia 1 (DISC1) in cardiac resilience to ischemic stressPreprint
Marwarha, G., Pinho, M. J., Scrimgeour, N. R., Slagsvold, K. H., Wahba, A., Røsbjørgen, R. E. N., Enguita, F. J., Yang, K., Ishizuka, K., Casas, C. A. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.09.494639 · Cited by 1
Movement disorders in psychiatry as symptom, as side effect, and as risk factor
Willems, A. E. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231109aw · Cited by 1
Treatment of hypertension in women and men
Ljungman, C. E. A. (2014) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Dysregulation of the kynurenine pathway in psychotic disorders : immunological aspects
Kegel, M. E. (2014) · Figshare
Cannabis, schizophrenia and other psychoses : longitudinal studies on Swedish conscripts
Manrique-Garcia, E. (2014) · Figshare
Management of Comorbid Medical Conditions in Schizophrenia
Rado, J. T. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0656-7_10
Searching for endophenotypes: negative symptoms and schizophrenia
Maier, E. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Björkholm, C. (2013) · Figshare
Being physically active : a bodily anchorage on the journey for recovery in mental ill-health
Lassenius, O. (2014) · Figshare
Cognition, Adherence and Stigma in Schizophrenia
Brain, C. (2015)
Preventive Health Care among Canadian Adults with Schizophrenia and Related Disorders
Beck, C. A. (2014) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27428
Innate Immune Response and Psychotic Disorders
Suvisaari, J., & Mantere, O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801968-9.00007-6
Kripalani, M. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.208.4.398
Wallace, E. (2015) · GSTF JOURNAL of Nursing and Health Care · doi:10.7603/s40743-015-0032-4
Eze, C. U., Ambakaderemo, T. E., & Desmond, E. (2015) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2015/15570
NonfastingScreeningforCardiovascular RiskAmongIndividualsTaking Second-GenerationAntipsychotics
Vanderlip, E. R., Chwastiak, L., & McCarron, R. M. (2014)
Masa-Font, R., Martin, M., & Mundet, X. (2013)
Chapter 10. Management of Leading Risk Factors for Cardiovascular Disease
Vanderlip, E. R., & Chwastiak, L. (2014) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615370009.lr10
Protection juridique et soins sans consentement chez le majeur hospitalisé en psychiatrie
Bougon, E. (2015) · HAL
NEGATIVE SYMPTOMS AND SCHIZOPHRENIA
Maier, E. B. (2014)
Presentatie van de Historisch Klinisch Toekomst - Revisie
Abma, R., Fielenbach, S., Gerlsma, C., Spreen, M., Castelein, S., Knegtering, R., van Meijel, B., van der Gaag, M., Gras, L. M., Swart, M., et al. (2014)
The Need for Tobacco Dependence Treatment
Lando, H. A. (2016) · Medical Research Archives · doi:10.18103/mra.v4i8.901
Quattrone, D., Ryland, H., Conde, E., & Sönmez, E. (2016) · Research Portal (King's College London)
PET studies on the immune cell marker TSPO in first episode psychosis patients
Collste, K. (2017) · Figshare
The Prevalence of Smoking and Its Associated Diseases
Li, M. D. (2018) · Springer eBooks · doi:10.1007/978-981-10-7530-8_1
Education About Mental Health and Illness: Innovative Approach for the Kenyan Context
Ndetei, D. M., Musyimi, C. W., Ruhara, R. W., Musau, A., & Mutiso, V. (2018) · Mental health and illness worldwide · doi:10.1007/978-981-10-0866-5_12-1
Troubles mentaux sévères et qualité des soins en oncologie
Lemogne, C. (2018) · Psycho-Oncologie · doi:10.3166/pson-2018-0033
Schizophrenia in Later Life: Public Policy Issues in the United States
Friedman, M. B., Furst, L., Nestadt, P. S., Williams, K. A., & Rodriguez, L. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108539593.019
Profil électrocardiographique et hémodynamique des patients ayant des troubles psychotiques
Amdouni, F., Khelifa, E., Longo, S., & Hechmi, Z. E. (2019) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2019.03.001
Wu, A. (2019) · TSpace (University of Toronto)
Roos, J. L. (2019) · Genetiese bevindings in ‘n groep Afrikaners met skisofrenie · doi:10.4102/aosis.2019.bk135.00
Vroeë afwykende niepsigotiese gedrag in skisofrenie
Roos, J. L. (2019) · Genetiese bevindings in ‘n groep Afrikaners met skisofrenie · doi:10.4102/aosis.2019.bk135.07
Vatbaarheid vir skisofrenie by 22q11.2-mikroweglatings
Roos, J. L. (2019) · Genetiese bevindings in ‘n groep Afrikaners met skisofrenie · doi:10.4102/aosis.2019.bk135.01
Kliniese kenmerke van Afrikaner-skisofreniepasiënte
Roos, J. L. (2019) · Genetiese bevindings in ‘n groep Afrikaners met skisofrenie · doi:10.4102/aosis.2019.bk135.02
Roos, J. L. (2019) · Genetiese bevindings in ‘n groep Afrikaners met skisofrenie · doi:10.4102/aosis.2019.bk135.08
Spesifieke chromosoomgebiede en/of kandidaatgene geïdentifiseer by skisofrenie
Roos, J. L. (2019) · Genetiese bevindings in ‘n groep Afrikaners met skisofrenie · doi:10.4102/aosis.2019.bk135.03
Recovery in Severe Mental Disorder and Comorbidity
Pangaonkar, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-19847-3_20
Comorbid Psychiatric and Physical Disorders
Chandran, S., Manohar, S., Maheshwari, S., & Rao, T. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-19847-3_19
Broniarczyk-Czarniak, M., Orzechowska, A., & Gałecki, P. (2020) · Pharmacotherapy in Psychiatry and Neurology · doi:10.33450/fpn.2020.07.002
Improving the Physical Health of Rural People Living with Mental Illness
Roberts, R. J. (2020) · Springer eBooks · doi:10.1007/978-981-10-5012-1_42-1
Polak, T. T., & Jacob, C. C. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_398-1
Klaassen, Z. W. A. (2019) · TSpace (University of Toronto)
Metabolic syndrome in the population of psychiatric patients in Novi Sad
Kuljančić, D. (2020) · Timocki medicinski glasnik · doi:10.5937/tmg2004145k
An inquiry into various aspects of clozapine use
van der Zalm, Y. C. (2021) · doi:10.26481/dis.20210618yz
Bocotan, L. (2021) · NORMA
Impacto de un programa de ejercicios en la aptitud física de las personas con esquizofrenia
Gomes, E., Corredeira, R., & Bastos, T. C. L. (2021) · doi:10.20873/abef.2595-0096v4n2p159171
Cognition, Adherence and Stigma in Schizophrenia. The COAST study
Brain, C. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)
[New method of radium treatment for cancer of the facial cavity; preliminary report].
Kisfaludy, P. (1953) · PubMed
Roos, J. L. (2019) · doi:10.4102/aosis.2019.bk135.05
Roos, J. L. (2019) · doi:10.4102/aosis.2019.bk135.06
Roos, J. L. (2019) · doi:10.4102/aosis.2019.bk135.04
PSYCHOSIS AS A MULTISYSTEM DISORDER – A GLOBAL PERSPECTIVE
Marinho, G., & Almeida, D. (2019) · doi:10.26226/morressier.5d1a036957558b317a13fb0a
(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811351-6.00026-7
Education About Mental Health and Illness: Innovative Approach for the Kenyan Context
Ndetei, D. M., Musyimi, C. W., Ruhara, R. W., Musau, A., & Mutiso, V. (2019) · Mental health and illness worldwide · doi:10.1007/978-981-10-2350-7_12
Paton, C. C., & Laugharne, R. A. (2013) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738013499322
Psychiatric disorders, diagnosed in psychiatric clinics, in patients with back pain: A cohort study
Iachina, M., Ljungdalh, P. S., Nørgård, B. M., Garvik, O. S., Stenager, E. N., & Schiøttz‐Christensen, B. (2022) · Scandinavian Journal of Public Health · doi:10.1177/14034948221100105
Polak, T. T., & Jacob, C. C. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_398
Premature Mortality among Patients with Mental Disorders: An International Literature Review
Darin, E. V., Амбарцумян, А. Р., & Питель, Д. А. (2023) · Психиатрия психотерапия и клиническая психология · doi:10.34883/pi.2022.13.4.004
Depression and Suicide in Regards to Sex
Matošić, A., Pašić, H., Silić, A., Vidrih, B., Puljić, A., & Vilibić, M. (2023) · Archives of Psychiatry Research · doi:10.20471/may.2023.59.01.11
Supporting successful clozapine treatment
Beex-Oosterhuis, M. M. (2023) · doi:10.5463/thesis.170
A Systematic Review and Meta-Analysis of the Prevalence of Schizophrenia in China From 2000 to 2020Preprint
Jin, H., Chen, H., Tao, H., Jin, W., & Sun, F. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4456597
Iwata, M., Hatano, M., Ito, K., Matsuzaki, H., & Yamada, S. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s425541
Rethinking Civil Commitment: The Radical Resources of the Ethics of Care
Hawthorne, S. C. C., & Ilhan, A. (2018) · Public Philosophy Journal · doi:10.59522/tpey2224
A review: using legumes to develop products for patients with psychiatric disorders
Plocina, L., & Beitāne, I. (2023) · Research for Rural Development/Research for Rural Development (Online) · doi:10.22616/rrd.29.2023.009
Karjalainen, E., Niemelä, M., Hakko, H. H., Wahlberg, K.-E., & Räsänen, S. (2024) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2024.2322495
The over‐35s: prediabetes and diabetes within an EIP service
Bandgar, R., Kelbrick, M., Paduret, G., & Jugon, S. (2024) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.830
Komorbidität: Was bedeutet sie und warum ist sie wichtig?
Brown, R. F., & Thorsteinsson, E. (2024) · Springer eBooks · doi:10.1007/978-3-031-55637-1_1
Lundmark, M., Allerby, K., Gremyr, A., & Andersson, A. (2024) · Research Square · doi:10.21203/rs.3.rs-4579887/v1
Carson, S. J., Scott, M., Rhodes, E., Batista, R., Tang, P., Prud’homme, D., Tanuseputro, P., & Webber, C. (2024) · PLOS mental health. · doi:10.1371/journal.pmen.0000013
Schizophrenia in the Elderly Population
Rizvi, S. Z. S., Qureshi, G., Khan, F. J., Mehboob, A., Khan, F., & Tabassum, F. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-0675-8.ch014
Zhou, W., Cao, W., Wang, W., Zeng, G., Liang, R., Liu, C., Chen, X., Lin, W.-C., Shi, X., Zhou, H., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1477953
Hintergründe und Epidemiologie
Hasan, A. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21442-4.00001-2
Mortality rate in patients in a long-term psychiatric care facility in Johannesburg
Mathekga, M., Mdaka, N., & Talatala, M. (2024) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v30i0.2329
General medical comorbidities in psychotic disorders in the Finnish SUPER study
Ahti, J., Kieseppä, T., Haaki, W., Suvisaari, J., Niemelä, S., Suokas, K., Torniainen‐Holm, M., Wegelius, A., Kampman, O., Lähteenvuo, M., et al. (2024) · Schizophrenia · doi:10.1038/s41537-024-00546-1 · Cited by 1
Progress of Clozapine Combination Therapy for Refractory Schizophrenia
李, 温. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.152307
Managing co-occurring physical disorders in mental health care
Hendrick, D. C., & Drake, R. E. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780198898818.003.0022
Axelsen, T. B., Sørensen, C. A., Lindelof, A., & Ludvigsen, M. S. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06653-2
Pachi, A., Tselebis, A., Kavourgia, E., Soultanis, N., Kasimis, D., Sikaras, C., Baras, S., & Ilias, Ι. (2025) · Healthcare · doi:10.3390/healthcare13141754
Bote, S. K., Hamid, A. A. A. M., & Chunarova, A. (2025) · Cureus · doi:10.7759/cureus.89257
The Evolution of an Outpatient Psychogeriatric Clinic in Southwestern Nigeria: an 18-Year Overview
Elugbadebo, O. O., Oyinlola, O., Alonge, T. O., & Baiyewu, O. (2025) · Ageing International · doi:10.1007/s12126-025-09642-8
Gibbs, A., Maripuu, M., Öhlund, L., Widerström, M., Nilsson, N., & Werneke, U. (2024) · Figshare · doi:10.6084/m9.figshare.25367389
Jønsson, A. B. R., Martiny, F., Søndergaard, M. K., Brodersen, J. B., Due, T. D., Nielsen, M. H., Bakkedal, C., Bardram, J. E., Bissenbakker, K. H., Christensen, I. E., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24257529
Naesager, A. H. D., Damgaard, S. N., Rozing, M. P., Siersma, V., Møller, A., & Jensen, K. T. (2024) · Figshare · doi:10.6084/m9.figshare.26710616
Sakinyte, K., & Holmberg, C. (2023) · Figshare · doi:10.6084/m9.figshare.22622662
Jønsson, A. B. R., Martiny, F., Søndergaard, M. K., Brodersen, J. B., Due, T. D., Nielsen, M. H., Bakkedal, C., Bardram, J. E., Bissenbakker, K. H., Christensen, I. E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24257612
Southern, J., Elliott, P., & Maidment, I. (2024) · Figshare · doi:10.6084/m9.figshare.26591072
Kirschner, V. S., Lamp, N., Dinc, Ü., Becker, T., Kilian, R., & Mueller-Stierlin, A. S. (2022) · Figshare · doi:10.6084/m9.figshare.17870326
Sakinyte, K., & Holmberg, C. (2023) · Figshare · doi:10.6084/m9.figshare.22622668
Sakinyte, K., & Holmberg, C. (2023) · Figshare · doi:10.6084/m9.figshare.22622659
Metadata
- Authors
- Crump, C., Winkleby, M. A., Sundquist, K., & Sundquist, J.
- Affiliations
- Lund University (SE)
- Venue
- American Journal of Psychiatry
- Published
- 2013-03
- Volume
- 170
- Issue
- 3
- Pages
- 324-333
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2157959378
- Cited by
- 619
- References
- 50
- Citations by year
- 2026: 20 · 2025: 28 · 2024: 49 · 2023: 58 · 2022: 47 · 2021: 51 · 2020: 58 · 2019: 63 · 2018: 40 · 2017: 59 · 2016: 40 · 2015: 39 · 2014: 46 · 2013: 20
- FWCI
- 34.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institute on Drug Abuse (R01DA030005)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Keywords
- schizophrenia, premature mortality, comorbidities, ischemic heart disease, cancer, sex differences, employment status, antipsychotic drugs, underdiagnosis, cardiovascular screening, cancer screening, primary care
- MeSH terms
- Adult, Aged, Aged, 80 and over, Ambulatory Care, Cause of Death, Female, Hospitalization, Humans, Life Expectancy, Male, Middle Aged, Neoplasms, Risk, Schizophrenia, Sweden, Cohort Studies, Comorbidity, Myocardial Ischemia, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
